Aseptic Meningitis after Recovery from SARS-CoV-2 in an Allogeneic Stem Cell Transplant Recipient. Issue 14 (April 2021)

• Record Type: Journal Article
• Authors: Basher, Fahmin; Camargo, Jose F; Diaz-Paez, Meilin; Lekakis, Lazaros J; Pereira, Denise L
• Is Part Of: Clinical medicine insights. Issue 14(2021)
• Publication Date: 2021-04
• Subjects: Meningitis -- coronavirus -- COVID-19 -- SARS-CoV-2 -- allogenic stem cell transplant; Clinical medicine -- Case studies -- Periodicals; Medicine; Clinical medicine; Electronic journals; Case Reports; Periodicals; Case Reports; Fulltext; Internet Resources; Periodicals; Case studies; Periodicals; 616.09
• DOI: 10.1177/11795476211009811
• Languages: English
• ISSNs: 1179-5476

Abstract

SARS-CoV-2 emerged as a worldwide pandemic in late 2019 and initially was described as a primary respiratory illness. The clinical manifestations of COVID-19 are now known to encompass nearly all organ systems, including the central nervous system. We present a case of an allogeneic hematopoietic stem cell transplant recipient who recovered from documented SARS-CoV-2 infection and later presented with symptoms of meningitis. While cerebrospinal fluid analysis did not reveal any bacterial or viral etiologies, evidence of an inflammatory state, including ophthalmologic findings of episcleritis, indicate what is likely the first reported case of aseptic meningitis associated with SARS-CoV-2 infection after initial clinical recovery.